Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or...
Saved in:
Main Authors | , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
14.11.2003
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered hetrocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5. |
---|---|
AbstractList | A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered hetrocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5. |
Author | BRACKEEN MARCUS O'CALLAGHAN JOHN MARK COBB JEFFREY EDMOND SHARP MATTHEW JUDE WILLSON TIMOTHY MARK BOSWELL GRADY EVAN DEATON DAVID NORMAN MOOK, ROBERT ANTHONY, JR COLLINS JON LOREN KALDOR ISTVAN ERICKSON GREG ALAN |
Author_xml | – fullname: BOSWELL GRADY EVAN – fullname: KALDOR ISTVAN – fullname: WILLSON TIMOTHY MARK – fullname: DEATON DAVID NORMAN – fullname: BRACKEEN MARCUS – fullname: SHARP MATTHEW JUDE – fullname: ERICKSON GREG ALAN – fullname: MOOK, ROBERT ANTHONY, JR – fullname: COLLINS JON LOREN – fullname: O'CALLAGHAN JOHN MARK – fullname: COBB JEFFREY EDMOND |
BookMark | eNqFyT0OwjAMQOEMMPB3BCRfIEMpCysViB2WTpVJTGOpTaLGLeT2dGBnetL71mrhg6eVqu_jMwnLKGThqF22Q_hkHR353GFn0Ac2gIYtWBp4QuGJErxZHGAbPCeZdZ4sGSRAjDjoFvset2r5wi7R7teN2l8vj-qmKYaGUkRDnqSp6kNZnM5F-c-_uXY7mA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 7 |
ExternalDocumentID | CY2319B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CY2319B13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:56:25 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CY2319B13 |
Notes | Application Number: CY20030000026 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031114&DB=EPODOC&CC=CY&NR=2319B1 |
ParticipantIDs | epo_espacenet_CY2319B1 |
PublicationCentury | 2000 |
PublicationDate | 20031114 |
PublicationDateYYYYMMDD | 2003-11-14 |
PublicationDate_xml | – month: 11 year: 2003 text: 20031114 day: 14 |
PublicationDecade | 2000 |
PublicationYear | 2003 |
RelatedCompanies | GLAXO GROUP LIMITED |
RelatedCompanies_xml | – name: GLAXO GROUP LIMITED |
Score | 2.5835981 |
Snippet | A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031114&DB=EPODOC&locale=&CC=CY&NR=2319B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1dS8MwFL3IFPVNp8OvSR6kb8FtbVd9KMLSjSHsA5myPY2kybbC1patKvv33qSd-qBvJYXQXHKak-TccwHu6rWZqs1sj85EI6ROo-FR4dqSekIKLpFyKFN5rtdvdl-d57E7LtQWOhfG-IR-GnNERFSIeM_M_zr9OcQKjLZycy8ibEqeOiM_sHa7Yxuh61hBy28PB8GAWYz5bGL1X3ykMY8t3CXtI4X2NBLaby2dkZL-Xk46J3AwxJ7i7BT2VFyGI7arulaGw15x2Y2PBe42ZzDR-M4v9SVx6GIrtfqEan3WdsmXGJ4kCgkPI0kkTqkP4-a9IfqQlfB5ot1xic5g0IUiSJaQNOVrOuerFT-Haqc9Yl2K3zj9DsaUTfKh2BUoxUmsLoDoXFdkElwo2XRcmz9ogx3lCpuHTYEM7hIqf_dx9d-LazjORWt1WnduoJSt31UVF99M3JrIfQHzh4zn |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH4xaMSbokRUtAezWyOwjelhMaGDoPIrBg2cSLsWJIFtganhv_e1gHrQ29IlzfrSb_3afu97ANfl0liVxrZHx6ISUqdS8ahwbUk9IQWXSDmUqTzX7lSbL87jwB1s1BY6F8b4hH4ac0REVIh4T83_Ovk5xAqMtnJ5I6bYFN83-n5gbXfHNkLXsYKaX-91gy6zGPPZ0Oo8-0hj7mq4S9pFeu1pJNRfazojJfm9nDQOYa-HPUXpEeyoKAdZtq26loP99uayGx83uFsew1Dje32pL4lD31ZSq0-o1metZnyG4YmnIeHhVBKJU-rDuHkviT5kJXwSa3dcojMYdKEIksYkSfiCTvh8zk-g2Kj3WZPiN46-gzFiw_VQ7DxkojhSp0B0risyCS6UrDquzW-1wY5yhc3DqkAGV4D8332c_ffiCrLNfrs1aj10ns7hYC1gK9OycwGZdPGuirgQp-LSRPELu4yP2g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Substituted+4-hydroxy-phenylalcanoic+acid+derivatives+with+agonist+activity+to+ppar-gamma&rft.inventor=BOSWELL+GRADY+EVAN&rft.inventor=KALDOR+ISTVAN&rft.inventor=WILLSON+TIMOTHY+MARK&rft.inventor=DEATON+DAVID+NORMAN&rft.inventor=BRACKEEN+MARCUS&rft.inventor=SHARP+MATTHEW+JUDE&rft.inventor=ERICKSON+GREG+ALAN&rft.inventor=MOOK%2C+ROBERT+ANTHONY%2C+JR&rft.inventor=COLLINS+JON+LOREN&rft.inventor=O%27CALLAGHAN+JOHN+MARK&rft.inventor=COBB+JEFFREY+EDMOND&rft.date=2003-11-14&rft.externalDBID=B1&rft.externalDocID=CY2319B1 |